FINWIRES · TerminalLIVE
FINWIRES

Xianju Pharmaceutical Passes Generic Drug Review for Progesterone Injection Specification

By

Zhejiang Xianju Pharmaceutical (SHE:002332) said the 1ml:50mg specification for progesterone injection passed China's generic drug consistency evaluation.

The injection is indicated for menstrual disorders, luteal deficiency, threatened and habitual abortion, premenstrual tension syndrome, and assisted reproductive therapy, according to a Wednesday filing with the Shenzhen bourse.

The pharmaceutical company already holds approvals for 1ml:10mg and 1ml:20mg specifications.

Shares of Zhejiang Xianju Pharmaceutical were down 2% Wednesday.

Related Articles

Asia

Market Chatter: CNOOC Begins Bohai Oilfield Full Production

CNOOC (SHA:600938, HKG:0883) started full production at the Kenli 10-2 oilfield phase one in the south Bohai Sea, China, Reuters reported Wednesday, citing state media.Daily output exceeded 20,440 barrels, according to the report.The oilfield, with proven geological reserves over 100 million metric tons, includes a central platform and two unmanned wellhead platforms, Reuters wrote.Shares of the oil company closed 3% lower on the Shanghai bourse and 2% on the Hong Kong bourse.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$HKG:0883$SHA:600938
Asia

Food & Life Co. Sets Up Joint Venture with KYORITSU to Address Sustainable Marine Resources

Food & Life Co. (TYO:3563) has decided to establish a joint venture with KYORITSU, following a board resolution on May 27, according to a Tokyo bourse filing on Wednesday.The venture, named FOOD & LIFE KYORITSU MARINE (provisional), aims to resolve the social issue of sustainable marine resource utilization by supporting aquaculture production.Food & Life Co. will hold a 60% stake in the 100 million yen capital joint venture, scheduled to launch in October, making it a specified subsidiary of F&LC.

$TYO:3563
Asia

Cummins India's Consolidated Profit Rises in Fiscal Q4; Shares Jump 12%

Cummins India's (NSE:CUMMINSIND, BOM:500480) consolidated attributable profit rose to 6.49 billion Indian rupees in the fiscal fourth quarter ended March 31, from 5.30 billion rupees a year ago.Earnings per share came in at 23.43 rupees versus 19.10 rupees a year earlier, the engine manufacturer said in a filing to the Indian stock exchanges on Wednesday.Revenue from operations in fiscal Q4 also increased 29.6 billion rupees from 24.3 billion rupees a year ago.The company's board recommended a final dividend of 46 rupees per equity share of face value 2 rupees each for the financial year 2025-26.Cummins' shares jumped nearly 12% in recent trade.

$BOM:500480$NSE:CUMMINSIND